Reducing High Risk Behavior in Treatment Court
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01481428 |
Recruitment Status
:
Completed
First Posted
: November 29, 2011
Last Update Posted
: January 10, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Substance Abuse HIV | Behavioral: Computer-facilitated HIV intervention Behavioral: Attention Control | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 371 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Prevention |
Official Title: | Delivering HIV Risk Reduction Services in Treatment Court |
Study Start Date : | September 2012 |
Actual Primary Completion Date : | December 2016 |
Actual Study Completion Date : | December 2016 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Attention Control |
Behavioral: Attention Control
Life skills training DVDs that match the duration of the anticipated experimental condition. The DVDs address topics such as positive listening skills, anger management, and stress reduction.
|
Experimental: Computer-facilitated HIV intervention |
Behavioral: Computer-facilitated HIV intervention
Individuals assigned to the experimental condition will complete the self-directed CARE HIV intervention during each of their first three sessions. The 20 minute intervention sessions involve several components including a brief risk assessment, review of identified risks, structured skill building videos, and the development of a risk prevention action plan. Because of the adaptive nature of the CARE program, the content of each session will be tailored to address the current risks of the participant. While the main focus of the intervention is on risk, individuals who report being HIV infected will receive a referral to treatment if they are not currently receiving medical care and their session will address, among other things, adherence to HIV care.
|
- Engagement in high risk behaviors [ Time Frame: 15 month follow-up ]Measured by the Risk Assessment Battery (RAB)
- Rate of HIV testing [ Time Frame: 15 month follow-up ]
- Condom Procurement [ Time Frame: 15 month follow-up ]
- Self-reported Condom Use [ Time Frame: 15 month follow-up ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- be at least 18 years of age;
- be charged with a non-violent felony offense
- have no more than two prior non-violent convictions or diversionary opportunities
- be willing to participate in the treatment court program for at least 12 months
- be in need of treatment for substance abuse or dependence as assessed by case management.
Exclusion Criteria:
- Elderly subjects and those with medical problems will be included in the research as long as they do not have any physical or psychiatric condition that would impede their ability to give competent consent to research participation or to understand the research instruments.
- Those individuals who are intoxicated, cognitively impaired, or psychiatrically unstable when approached will not be included; however, such individuals may subsequently be included if the disqualifying condition subsides.
- Spanish speaking only individuals.
- Client remanded to jail or residential treatment facilities at the time of Treatment Court enrollment.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01481428
United States, Pennsylvania | |
Philadelphia Treatment Court | |
Philadelphia, Pennsylvania, United States, 19107 |
Principal Investigator: | David S Festinger, Ph.D. | Treatment Research Institute |
Responsible Party: | Treatment Research Institute |
ClinicalTrials.gov Identifier: | NCT01481428 History of Changes |
Other Study ID Numbers: |
#1002 R01DA030257 ( U.S. NIH Grant/Contract ) |
First Posted: | November 29, 2011 Key Record Dates |
Last Update Posted: | January 10, 2017 |
Last Verified: | January 2017 |
Keywords provided by Treatment Research Institute:
High risk behavior Drug court clients Substance abuse HIV intervention Treatment Court Clients |
Additional relevant MeSH terms:
Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |